Dell-backed cybersecurity software producer Netskope has raised just over $1bn to date, having completed a $300m round led by Iconiq Growth.

Bow Capital has helped supply fresh funding for the equity-free capital provider to boost its expansion and broaden its product offering.

SoftBank Vision Fund 2 and Intuit helped supply fresh funding for the equity-free capital provider to boost its expansion and broaden its product offering.

Block.one's blockchain technology spinoff is joining forces with publicly listed Far Peak Acquisition Corporation at a $9bn valauation.

GV participated in a series C round for the online flexible staffing portal at a valuation of $560m, hiking its overall funding to $100m.

Munich Re and Microsoft helped CO2-to-chemicals technology provider Twelve raise $57m while Eli Lilly and Kaiser Permanente-backed CRO dMed-Clinipac secured $50m.

The blockchain payment technology provider is set to undergo a $4.5bn reverse takeover having previously secured over $680m from investors including FTX, Baidu, Bitmain, CreditEase and Wanxiang.

The precision oncology platform is based on research by Duke and Hubrecht Institute faculty and the cash will fund technology development and clinical studies.

The Sanofi-backed vaccine developer has filed to float on the Nasdaq Global Select Market and set a placeholder target of $100m.

GV contributed to the precision oncology platform developer's series A round, which will fund technology development and clinical studies.